Clik here to view.
拓臻生物将在2019美国肝病研究协会年会上发表FXR激动剂TERN-101临床前研究数据
美国加州福斯特城与中国上海 (美国商业资讯)–Terns Pharmaceuticals...
View ArticleClik here to view.
Terns Pharmaceuticals to Present Positive Preclinical Data on FXR Agonist...
FOSTER CITY, Calif. & SHANGHAI Terns Pharmaceuticals, Inc., a global biopharmaceutical company focused on discovering and developing innovative therapies to treat non-alcoholic steatohepatitis...
View ArticleClik here to view.
C-Path, CDISC Develop Standard to Represent Data for Animal Rule Studies
TUCSON, Ariz. & AUSTIN, Texas The Critical Path Institute (C-Path) and CDISC are pleased to announce the release of a global Foundational Standard that describes how to represent data for the...
View ArticleClik here to view.
Sun Pharma Launches Drizalma Sprinkle in the U.S.
MUMBAI, India & PRINCETON, N.J. Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, “Sun Pharma” including its subsidiaries and/or associate...
View ArticleClik here to view.
HitGen Enters into DNA-Encoded Library Based Drug Discovery Research...
CHENGDU, China HitGen Inc. today announced that it has entered into a drug discovery research collaboration with Galapagos NV to identify potential small molecule leads against targets of interest...
View ArticleClik here to view.
Accomplishments of Dr. Steven Rosenberg in Cancer Immunotherapy Inspire Young...
TOKYO Utilizing the capability of one’s own immune system to tackle cancer, an out-of-the box idea was the brain child of Dr. Steven Rosenberg almost three decades ago. His initiative which paved...
View ArticleClik here to view.
Terns Pharmaceuticalsが2019年米国肝臓学会議でFXR作動薬TERN-101の良好な前臨床データを発表へ
米カリフォルニア州フォスターシティ & 上海 （ビジネスワイヤ） — 非アルコール性脂肪肝炎（NASH）とがんの革新的治療薬の創薬と開発に傾注する世界的バイオ製薬会社のTerns Pharmaceuticals,...
View ArticleClik here to view.
Vaxess and GC Pharma to Collaborate on Development of Highly Effective...
CAMBRIDGE, Mass. & SEOUL, South Korea GC Pharma, a leading manufacturer of influenza vaccines with a global reach, and Vaxess, an innovative biotechnology company developing the MIMIX smart...
View ArticleClik here to view.
Steven Rosenberg博士在癌症免疫治疗领域的成就激励日本的年轻研究人员，印度获奖人赢得第14届干细胞Fujio Cup Quiz
东京 (美国商业资讯)–利用个体自身免疫系统的功能来应对癌症，这一开箱即用的概念是约三十年前由Steven Rosenberg博士提出的。他的倡议为肿瘤学的新篇章铺平了道路，激励着日本东京召开的2019年度NCRM NICHE上的众多年轻科学家和临床工作者，他在江户川NICHE颁奖仪式上的获奖感言进行了视频直播。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
NeuClone Announces First Human Dose of Stelara® (Ustekinumab) Biosimilar...
SYDNEY NeuClone, a clinical-stage biopharmaceutical company exclusively focused on developing high-quality biosimilar products, today announced it has commenced dosing of Stelara® (ustekinumab)...
View ArticleClik here to view.
The Lancet Respiratory Medicine Published Study Shows Ensartinib Holds...
PALM BEACH GARDENS, Fla. Xcovery Holdings, Inc., an oncology-focused biopharmaceutical company, today announced that ensartinib, the company’s lead drug candidate, demonstrated efficacy and safety...
View ArticleClik here to view.
がん免疫療法におけるスティーブン・ローゼンバーグ博士の偉業が日本の若い研究者の刺激に、幹細胞に関する第14回フジオカップクイズはインドのチームが優勝
東京 （ビジネスワイヤ） — 自己の免疫系が持つ能力を利用してがんと闘うという独創的なアイデアは、30年近く前にスティーブン・ローゼンバーグ博士が考案したものです。腫瘍学における新たな章の幕開けを告げた博士のイニシアチブは、東京で開催されたNCRM NICHE 2019で江戸川NICHE賞の受賞セレモニーにおける博士の受賞スピーチが上映された際に多くの若い科学者や臨床医に刺激を与えました。...
View ArticleClik here to view.
Vertex Announces Reimbursement of Cystic Fibrosis Medicines SYMDEKO®...
LONDON Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) today announced that SYMDEKO® (tezacaftor/ivacaftor and ivacaftor) is reimbursed in Australia for people with cystic fibrosis (CF) ages 12...
View ArticleClik here to view.
Retrospective Real-World Comparative Analysis Highlights Safety of...
OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced results from a retrospective chart review study (EVOLVE), which investigated the likelihood of...
View ArticleClik here to view.
Takeda Acquires License for First-In-Class Celiac Disease Therapy from COUR...
OSAKA, Japan & CHICAGO Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) and COUR Pharmaceutical Development Company, Inc. (“COUR”) today announced that Takeda has acquired an...
View ArticleClik here to view.
Longhorn Vaccines & Diagnostics to Present at The 50th Union World Conference...
BETHESDA, Md. Longhorn Vaccines & Diagnostics an innovative molecular tool, assay and vaccine development company focused on serving unmet critical needs in both developed and developing...
View ArticleClik here to view.
在2a期概念验证研究取得积极结果后，武田获得COUR Pharmaceuticals治疗乳糜泻的同类首创药物的许可
日本大阪和芝加哥 (美国商业资讯)–武田药品工业株式会社(TSE:4502/NYSE:TAK)（“武田”）和COUR Pharmaceutical Development Company, Inc....
View ArticleClik here to view.
立足本地，服务中国-库克中国园区开工仪式开启
上海 库克中国园区开工仪式在上海市西虹桥青浦区顺利举行。来自上海市青浦区的有关领导、西虹桥商务区的相关负责人以及库克医疗的管理层共同参加了这一盛典。 本新闻稿包含多媒体。此处查看新闻稿全文： https://www.businesswire.com/news/home/20191023005955/zh-CN/ (Photo: Business Wire)...
View ArticleClik here to view.
Committed to Patients in China – Groundbreaking Ceremony for Cook China Campus
SHANGHAI Cook Medical performed a groundbreaking ceremony on its new operation center in Shanghai West Hongqiao Business District, attended by leaders and the management team from Shanghai Qingpu...
View ArticleClik here to view.
注意-更正并替换：立足本地，服务中国-库克中国园区开工仪式开启
上海 (上海) 2019年9月9日，库克中国园区开工仪式在上海市西虹桥青浦区顺利举行。来自上海市青浦区的有关领导、西虹桥商务区的相关负责人以及库克医疗的管理层共同参加了这一盛典。 本新闻稿包含多媒体。此处查看新闻稿全文： https://www.businesswire.com/news/home/20191023005955/zh-CN/ 上海市青浦区商务委副主任张正义在开工仪式上发表讲话...
View Article